Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations

Detalles Bibliográficos
Autores principales: Kingston, Belinda, Bailleux, Caroline, Delaloge, Suzette, Schiavon, Gaia, Scott, Veronique, Lacroix-Triki, Magali, Carr, T. Hedley, Kozarewa, Iwanka, Gevensleben, Heidrun, Kemp, Zoe, Pearson, Alex, Turner, Nicholas, André, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446515/
https://www.ncbi.nlm.nih.gov/pubmed/32923864
http://dx.doi.org/10.1200/PO.19.00130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446515/
https://www.ncbi.nlm.nih.gov/pubmed/32923864
http://dx.doi.org/10.1200/PO.19.00130

Ejemplares similares